Bristol-Myers Squibb
BMY
#173
Rank
A$175.18 B
Marketcap
A$86.02
Share price
-0.33%
Change (1 day)
-2.46%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): A$4.61

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$4.18. In 2024 the company made an earnings per share (EPS) of A-$6.22 a decrease over its 2023 EPS that were of A$5.46.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.61-174.07%
2024A-$6.22-213.92%
2023A$5.4630.2%
2022A$4.20-6.04%
2021A$4.47-179.29%
2020A-$5.63-281.37%
2019A$3.11-27.21%
2018A$4.27
2016A$3.76175.26%
2015A$1.37-19.83%
2014A$1.70-22.44%
2013A$2.2034.48%
2012A$1.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.68 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.36 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.91-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.37-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.41 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.18 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.91-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$15.47 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.29 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.53 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK